Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-312.46%Return on Equity
VS
Market
Sector
Industry
History
$ 3.15Close
$ 2.08 - $ 6.95 52-Week Range
Ticker Information
Ticker
VVOSCompany Name
VIVOS THERAPEUTICS INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQVIVOS THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VVOS - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 4.58M | $ -14.32M | -312.46% |
| 3/31/2025 | $ 4.41M | $ -11.24M | -254.98% |
| 12/31/2024 | $ 7.95M | $ -11.14M | -140.01% |
| 9/30/2024 | $ 7.67M | $ -12.57M | -163.97% |
| 6/30/2024 | $ 6.35M | $ -12.04M | -189.77% |
| 3/31/2024 | $ 582K | $ -15.64M | -2687.8% |
| 12/31/2023 | $ 411K | $ -13.58M | -3304.87% |
| 9/30/2023 | $ 46K | $ -15.41M | -33506.52% |
| 6/30/2023 | $ 2.11M | $ -18.75M | -890.5% |
| 3/31/2023 | $ 6.99M | $ -20.22M | -289.12% |
Key Performance Insights, Last 5 Years
- VIVOS THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, VIVOS THERAPEUTICS INC's average ROE has been -2678.75%.
- The median ROE for VIVOS THERAPEUTICS INC during this period was -255.09%
- VIVOS THERAPEUTICS INC reached its highest ROE over the past 5 years at -74.92%.
- The lowest ROE recorded by VIVOS THERAPEUTICS INC in the same timeframe -33506.52%
VIVOS THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for VIVOS THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -11.75M ] / Equity [ $ -2.94M ]
(=) ROE [ 0% ] VVOS - Return on Equity, Last 5 years
-33506.52%
Minimum
Sep 30, 2023
-74.92%
Maximum
Sep 30, 2021
-2678.75%
Average
-255.09%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.56% with a standard deviation of 22.62%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.66% |
| max | 73.25% |
| average | 1.56% |
| median | 6.45% |
| std | 22.62% |